Bioorganic & Medicinal Chemistry Letters 2010-04-15

4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.

Qiang Tan, Aimie M Ogawa, Ronald E Painter, Young-Whan Park, Katherine Young, Frank P DiNinno, Qiang Tan, Aimie M. Ogawa, Ronald E. Painter, Young-Whan Park, Katherine Young, Frank P. DiNinno

Index: Bioorg. Med. Chem. Lett. 20 , 2622-4, (2010)

Full Text: HTML

Abstract

4,7-Dichloro-1-benzothien-2-yl sulfonylaminomethyl boronic acid (DSABA, Compound I) was discovered as the first boronic acid-based class D beta-lactamase inhibitor. It exhibited an IC(50) of 5.6 microM against OXA-40. The compound also inhibited class A and C beta-lactamases with sub to low microM IC(50), and synergized with imipenem against Acinetobacter baumannii.Copyright 2010 Elsevier Ltd. All rights reserved.


Related Compounds

Related Articles:

Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.

2014-11-01

[J. Antibiot. 67(11) , 763-9, (2014)]

The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.

2015-03-01

[J. Gastroenterol. Hepatol. 30 Suppl 1 , 60-5, (2015)]

Synthesis and structures of tridentate ketoiminate zinc complexes bearing trifluoromethyl substituents that act as L-lactide ring opening polymerization initiators.

2013-04-21

[Dalton Trans. 42(15) , 5573-86, (2013)]

Mixed-ligand chelate extraction of trivalent lanthanides with 4,4,4-trifluoro-1-phenyl-1,3-butanedione and neutral oxo-donors.

1997-01-01

[Talanta 44(1) , 97-103, (1997)]

First bite syndrome: Our experience with intraparotid injections with botulinum toxin type A.

2016-01-01

[Laryngoscope 126 , 104-7, (2016)]

More Articles...